Could Mean Platelet Volume Serve as a Prognostic Indicator for Outcomes in Cancer?
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Many cancer patients may be treated with drugs that were granted accelerated approval but do not provide a clinical benefit, a study suggests.
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.
A study examined the rates of postoperative complications and death following surgery for colorectal, lung, gastric, and breast cancer.